|
1
|
Pedersen J, Coskun M, Soendergaard C,
Salem M and Nielsen OH: Inflammatory pathways of importance for
management of inflammatory bowel disease. World J Gastroenterol.
20:64–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khor B, Gardet A and Xavier RJ: Genetics
and pathogenesis of inflammatory bowel disease. Nature.
474:307–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Strowig T, Henao-Mejia J, Elinav E and
Flavell R: Inflammasomes in health and disease. Nature.
481:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Martinon F, Agostini L, Meylan E and
Tschopp J: Identification of bacterial muramyl dipeptide as
activator of the NALP3/cryopyrin inflammasome. Curr Biol.
14:1929–1934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanneganti TD, Body-Malapel M, Amer A, et
al: Critical role for cryopyrin/Nalp3 in activation of caspase-1 in
response to viral infection and double-stranded RNA. J Biol Chem.
281:36560–36568. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanneganti TD, Özören N, Body-Malapel M,
et al: Bacterial RNA and small antiviral compounds activate
caspase-1 through cryopyrin/Nalp3. Nature. 440:233–236. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmitz J, Owyang A, Oldham E, et al:
IL-33, an interleukin-1-like cytokine that signals via the IL-1
receptor-related protein ST2 and induces T Helper type 2-associated
cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petrilli V, Papin S, Dostert C, Mayor A,
Martinon F and Tschopp J: Activation of the NALP3 inflammasome is
triggered by low intracellular potassium concentration. Cell Death
Differ. 14:1583–1589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mariathasan S, Weiss DS, Newton K, et al:
Cryopyrin activates the inflammasome in response to toxins and ATP.
Nature. 440:228–232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martinon F, Petrilli V, Mayor A, Tardivel
A and Tschopp J: Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 440:237–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bryant C and Fitzgerald KA: Molecular
mechanisms involved inflammasome activation. Trends Cell Biol.
19:455–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agostini L, Martinon F, Burns K, McDermott
MF, Hawkins PN and Tschopp J: NALP3 forms an IL-1β-processing
inflammasome with increased activity in Muckle-Wells
Autoinflammatory disorder. Immunity. 20:319–325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bauernfeind F, Ablasser A, Bartok E, et
al: Inflammasomes: current understanding and open questions. Cell
Mol Life Sci. 68:765–783. 2011. View Article : Google Scholar
|
|
14
|
Lam kanfi M, Sarkar A, Vande Walle L, et
al: Inflammasome-dependent release of the alarmin HMGB1 in
endotoxemia. J Immunol. 185:4385–4392. 2010. View Article : Google Scholar
|
|
15
|
Vitali R, Stronati L, Negroni A, et al:
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in
pediatric inflammatory bowel disease. Am J Gastroenterol.
106:2029–2040. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu B, Nakamura T, Inouye K, et al: Novel
role of PKR in inflammasome activation and HMGB1 release. Nature.
488:670–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dey M, Cao C, Dar AC, et al: Mechanistic
link between PKR dimerization, autophosphorylation, and eIF2alpha
substrate recognition. Cell. 122:901–913. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Williams BR: Role of the double-stranded
RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc
Trans. 25:509–513. 1997.PubMed/NCBI
|
|
19
|
Bullido MJ, Martinez Garcia A, Tenorio R,
et al: Double stranded RNA activated EIF2 alpha kinase
(EIF2AK2;PKR) is associated with Alzheimer’s disease. Nerobiol
Aging. 29:1160–1166. 2008. View Article : Google Scholar
|
|
20
|
Heneka MT, Kummer MP, Stutz A, et al:
NLRP3 is activated in Alzheimer’s disease and contributes to
pathology in APP/PS1 mice. Nature. 493:674–678. 2013. View Article : Google Scholar
|
|
21
|
Lennard-Jones JE: Classification of
inflammatory bowel disease. Scand J Gastroenterol. 24:2–6. 1989.
View Article : Google Scholar
|
|
22
|
Silverberg MS, Satsangi J, Ahmad T, et al:
Toward an integrated clinical, molecular and serological
classification of inflammatory bowel disease: report of a working
party of the 2005 montreal world congress of gastroenterology. Can
J Gastroenterol. 19:5–36. 2005.
|
|
23
|
Fransén K, Franzén P, Magnuson A, et al:
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and
the development of Crohn’s disease. PLoS One. 8:e727392013.
View Article : Google Scholar
|
|
24
|
Franke A, Rosenstiel P, Balschun T, et al:
No association between the TUCAN (CARD8) Cys10Stop mutation and
inflammatory bowel disease in a large retrospective German and
clinically well-characterized Norwegian sample. Gastroenterology.
132:2080–2081. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Büning C, Schmidt HH, Molnár T, et al: No
association of the CARD8 (TUCAN) c. 30T>A (pC10X) variant with
Crohns disease: A study in 3 independent European Cohorts. Inflamm
Bowel Dis. 14:332–337. 2008. View Article : Google Scholar
|
|
26
|
Fisher SA, Mirza MM, Onnie CM, et al:
Combined evidence from three large British association studies
rejects TUCAN/CARD8 as an IBD susceptibility gene.
Gastroenterology. 132:2078–2080. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McGovern DPB, Butler H, Ahmad T, et al:
TUCAN (CARD8) genetic variants and inflammatory bowel disease.
Gastroenterology. 131:1190–1196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zaki MH, Lamkanfi M and Kanneganti TD: The
Nlrp3 inflammasome contributions to intestinal homeostasis. Trends
Immunol. 32:171–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schoultz I, Verma D, Halfvarsson J, et al:
Combined polymorphisms in genes encoding the inflammasome
components NALP3 and CARD8 confer susceptibility to crohn’s disease
in swedish men. Am J Gastroenterol. 104:1180–1188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Verma D, Lerm M, Blomgran Julinder R,
Eriksson P, Söderkvist P and Särndahl E: Gene polymorphisms in the
NALP3 inflammasome are associated with interleukin-1 production and
severe inflammation: relation to common inflammatory diseases?
Arthritis Rheum. 58:888–894. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Palomer E, ILL-Raga G, Tajes M, et al: PKR
and PP1C polymorphisms in Alzheimer’s disease risk. Neurosci Med.
2:226–231. 2011. View Article : Google Scholar
|
|
32
|
Hsu LC, Park JM, Zhang K, et al: The
protein kinase PKR is required for macrophage apoptosis after
activation of Toll-like receptor 4. Nature. 428:341–345. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nakamura T, Furuhashi M, Li P, et al:
Double-stranded RNA-dependent protein kinase links pathogen sensing
with stress and metabolic homeostasis. Cell. 140:338–348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu B, Wang H, Andersson U and Tracey KJ:
Regulation of HMGB1 release by inflammasomes. Protein Cell.
4:163–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
